CFM Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,297
Closed -$290K 150
2023
Q2
$290K Buy
3,297
+48
+1% +$4.13K 0.07% 140
2023
Q1
$262K Buy
+3,249
New +$265K 0.07% 138
2022
Q4
Sell
-3,460
Closed -$279K 160
2022
Q3
$279K Hold
3,460
0.09% 128
2022
Q2
$311K Sell
3,460
-147
-4% -$14.9K 0.09% 130
2022
Q1
$400K Buy
3,607
+127
+4% +$13.4K 0.1% 129
2021
Q4
$369K Sell
3,480
-460
-12% -$53.3K 0.08% 131
2021
Q3
$493K Buy
3,940
+66
+2% +$8.54K 0.12% 112
2021
Q2
$481K Sell
3,874
-160
-4% -$20.1K 0.13% 104
2021
Q1
$477K Sell
4,034
-6,008
-60% -$704K 0.14% 100
2020
Q4
$1.18M Sell
10,042
-2,332
-19% -$257K 0.38% 58
2020
Q3
$1.28M Sell
12,374
-1,869
-13% -$188K 0.47% 45
2020
Q2
$1.31M Sell
14,243
-2,093
-13% -$201K 0.5% 46
2020
Q1
$1.47M Buy
+16,336
New +$1.74M 0.68% 37

Other funds holding MDT

CFM Wealth Partners's MDT Position: Q3 2023 in Review

CFM Wealth Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 3,297 shares — an estimated $290K sold.

CFM Wealth Partners first reported a position in MDT in Q1 2020 and held it in 13 quarters. The position peaked at $1.47M in Q1 2020. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • CFM Wealth Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • CFM Wealth Partners sold 3,297 Medtronic shares in Q3 2023, an estimated $290K.
  • CFM Wealth Partners first reported a position in Medtronic in Q1 2020 and held it in 13 quarters.
  • CFM Wealth Partners's Medtronic position peaked at $1.47M in Q1 2020.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on CFM Wealth Partners's 13F filing for Q3 2023, filed 11 Oct 2023.